Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.150
-0.005 (-0.12%)
Jan 29, 2026, 4:00 PM EST - Market closed
Molecular Partners AG Stock Forecast
Stock Price Forecast
The 2 analysts that cover Molecular Partners AG stock have a consensus rating of "Buy" and an average price target of $8.38, which forecasts a 101.92% increase in the stock price over the next year. The lowest target is $3.75 and the highest is $13.
Price Target: $8.38 (+101.92%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molecular Partners AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +213.25% | Jan 27, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $4 → $3.75 | Hold | Maintains | $4 → $3.75 | -9.64% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $4.5 → $4 | Hold | Maintains | $4.5 → $4 | -3.62% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | +8.43% | Dec 5, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $30 → $8 | Buy → Hold | Downgrades | $30 → $8 | +92.77% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
680.00K
from 4.97M
Decreased by -86.32%
Revenue Next Year
7.48M
from 680.00K
Increased by 999.99%
EPS This Year
-1.56
from -1.59
EPS Next Year
-1.52
from -1.56
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.1M | 23.1M | ||||
| Avg | 680,003 | 7.5M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -57.7% | 3,297.0% | ||||
| Avg | -86.3% | 1,000.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.45 | -0.62 | ||||
| Avg | -1.56 | -1.52 | ||||
| Low | -1.57 | -1.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.